Until the first patent for NuvaRing expires in April 2018, other drug companies cannot manufacture any generic NuvaRing products. Unless circumstances arise to extend the exclusivity period beyond 2018 (such as lawsuits or new patents), it is expected that several companies will begin producing a generic NuvaRing at that time.
Is a Generic NuvaRing Available?
NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring) is a prescription contraceptive product. It is very similar to combined oral contraceptives (birth control pills), except that it is used as a vaginal ring that is replaced monthly.
NuvaRing is made by Organon, one of the largest manufacturers of contraceptive products. NuvaRing is currently under the protection of a patent that prevents any generic NuvaRing from being manufactured in the United States.
When Will Generic NuvaRing Be Available?
The first patent for NuvaRing currently expires in April 2018. This is the earliest possible date that a generic version of NuvaRing could become available. However, there are other circumstances that could come up to extend the exclusivity period of NuvaRing beyond 2018. This could include such things as other patents for specific NuvaRing uses or lawsuits. Once NuvaRing goes off patent, there may be several companies that will begin manufacturing generic NuvaRing products.
Will My Insurance Cover NuvaRing?
Each insurance company is different. There has been a long history of insurance companies not covering contraceptive products, although this is beginning to change. More and more insurances are beginning to cover contraceptives. Because NuvaRing is not available in a generic form, you may have to pay a higher copayment.